The global infectious disease diagnostics market size stood at around USD 14.3 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Infectious diseases are one of the leading causes of morbidity and mortality across the globe. Diagnostics is the primary step for the disease discovery and treatment leading to eradication of infectious diseases. Owing to ever-evolving pathogens and emerging new diseases, there is dire need to identify suitable diagnostics technique that can help physicians to decide appropriate treatment. This can also help to control the outbreak of the disease in the population. Technological advancement has rapidly changed the landscape of infectious disease diagnostics. Scientific research and development activities in novel technologies and technique such as mass spectrometry and next-generation sequencing (NGS) are changing the way how rapid diagnostics are being performed to detect diseases.
The growing prevalence of infectious diseases and high prevalence is a major factor driving the growth of the global infectious disease market. In addition, technological advances in diagnostic instruments, the government’s initiative to develop appropriate healthcare infrastructure in emerging economies, and a greater understanding of diagnosis in developed economies will enhance the development of the global infectious disease diagnostics.
A major and growing trend in the epidemiology market is the increasing adoption of technologically advanced visual diagnostic equipment in healthcare organizations in emerging economies. This is the factor to boost global market growth over the forecast period.
Growth in the infectious disease diagnostics market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics.
Major Infectious Disease
The major infectious disease includes hepatitis, Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG), Hospital-Acquired Infections, Human Papillomavirus (HPV), Tuberculosis (TB), Influenza and other infectious diseases.
Viral Infection diagnostics are expected to cover a large share of the market. A viral infection is one of the major public health concerns around the world. Owing to the high prevalence of these dreadful illnesses, the demand for early diagnostic tests is expected to increase as early diagnosis may reduce the spread of the disease. Hence, this market is expected to increase in the future.